The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 25, Issue SUPPL. 3, 2005, Pages

  Li, Philip Kam Tao ^a   Chow, Kai Ming ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiovascular mortality; Epidemiology; Residual renal function

Indexed keywords

ANGIOTENSINOGEN; C REACTIVE PROTEIN; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; RAMIPRIL;

BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL OBSERVATION; DATA ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; GENETIC RISK; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HONG KONG; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL RATE; UREMIA;

EID: 21244506778     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502503s20     Document Type: Review

References (21)

1. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 2003; 18:977-82.
2. National Kidney Foundation. K/DOQI chnical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1):S170-266.
3. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3):S112-19.
4. United States Renal Data System. USRDS 2002 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
5. Weiner DE, Tighiouart H, Stark PC, Amin MG, Macleod B, Griffith JL, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004; 44:198-206.
6. Uhlig K, Levey AS, Sarnak MJ. Traditional cardiac risk factors in individuals with chronic kidney disease. Semin Dial 2003; 16:118-27.
7. Madore F. Uremia-related metabolic cardiac risk factors in chronic kidney disease. Semin Dial 2003; 16:148-56.
8. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62:630-47.
9. Wang AY, Wang M, Woo J, Lai CW, Lui SF, Li PK, et al. Inflammation, residual renal function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15:2186-94.
10. Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2004 [in press].
11. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, et al. Is a single time point C-reactive protein predictive of out-come in peritoneal dialysis patients? J Am Soc Nephrol 2003; 14:1871-9.
12. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004; 15:1061-70.
13. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 2003; 139: 105-12.
14. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimbürger O, Lindholm B. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004; 24: 327-39.
15. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 2002; 62: 1417-22.
16. Chow KM, Szeto CC, Kum LC, Kwan BC, Fung TM, Wong TY, et al. Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol 2003; 16:878-85.
17. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
18. Wong TY, Szeto CC, Chow KM, Chan JC, Li PK. Contribution of gene polymorphisms in the renin-angiotensin system (RAS) to macroangiopathy in patients with diabetic nephropathy. Am J Kidney Dis 2001; 38: 9-17.
19. Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, et al. Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 2003; 63:1899-907.
20. Li PK, Chow KM, Szeto CC. Is there a survival advantage in Asian peritoneal dialysis patients? Int J Artif Organs 2003; 26:363-72.
21. Li PK, Szeto CC. Peritoneal dialysis adequacy in Asia - is higher better? Perit Dial Int 2003; 23(Suppl2):S65-8.